Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Investigations into the use of radiolabeled monoclonal antibodies for selective cell labeling in whole blood: Progress report, January 1986-December 1986

Technical Report ·
OSTI ID:6782611
Techniques to effectively labeling blood cell specific monoclonal antibodies (MAbs), with In-111 using bifunctional chelating agents such as the cyclic or mixed anhydride of diethylenetriaminepentaacetic acid have been developed. Conditions for the optimal labeling of blood cells are reported. The specificity (Kd values) of In-111 labeled MAbs for the cell specific antigens are reported. In-111-MAb labeled canine platelets were used to image vascular thrombi. Under the best experimental conditions approximately 70% of the radiolabeled MAbs get incorporated into isolated blood cells. However, only about 35% of the added MAb-associated radioactivity would incorporate into the desired type of blood cells in whole blood. The chemical nature of the radioactivity that does not bind to the cells was investigated. 9 figs., 6 tabs.
Research Organization:
Thomas Jefferson Univ., Philadelphia, PA (USA). Hospital
DOE Contract Number:
FG02-85ER60295
OSTI ID:
6782611
Report Number(s):
DOE/ER/60295-2; ON: DE87005410
Country of Publication:
United States
Language:
English

Similar Records

(Investigations into the use of radiolabeled monoclonal antibodies for selective cell labeling in whole blood):
Technical Report · Wed Dec 31 23:00:00 EST 1986 · OSTI ID:5242650

Evaluation of indium-111 labeled B79. 7 monoclonal antibodies as an agent for radiolabeling of human platelets
Conference · Wed May 01 00:00:00 EDT 1985 · J. Nucl. Med.; (United States) · OSTI ID:7032508

Evaluation of I-123 and In-111 labeled anti-platelet monoclonal antibody for the scintigraphic localization of in vivo thrombi
Conference · Sat Dec 31 23:00:00 EST 1983 · J. Nucl. Med.; (United States) · OSTI ID:6932277